VRF Field Report • Miramar, Florida
Veterans, researchers and advocates come together in Miramar to rethink the road to vitiligo care — and who gets seen along the way.
A gathering of veterans, clinicians, policymakers and patient advocates in Miramar launched two research projects, reshaped the Vitiligo Patient Journey Map, and raised a question about who gets seen in vitiligo advocacy.
There are easier ways to get from Toronto to Fort Lauderdale. A routine one-stop flight turned into a two-day expedition through airports, taxis, an unplanned hotel and enough weather delays to make me question my love of travel. Luckily, I had built in a spare day before the conference. Without it, I might still be arguing with an airline chatbot about what “confirmed connection” means.
I finally landed in Fort Lauderdale on Friday, November 13. A couple of hours later, a major FAA systems disruption affected air traffic across the United States. The trouble reportedly involved aging communications infrastructure during a system upgrade. Apparently, modernizing America's air traffic control is a little more complicated than clicking “Install Update.”
The timing was rough for Honor Without Exception: Vitiligo in the Armed Forces, scheduled for the next morning at Miramar City Hall. Some speakers and guests never made it. The organizers adapted, and the symposium went ahead with a strong mix of medical expertise, military experience and patient advocacy.
Why vitiligo in uniform?
A white patch on a soldier raises three very different questions. Can I join? Can I stay? Did my service cause it, or make it worse? The diagnosis is the same, but each question has its own rules, paperwork and standard of evidence.
There is no global military standard for vitiligo. In the United States, the February 2026 Defense Department accession standards don't list vitiligo among disqualifying skin conditions, and retention is decided case by case. The UK's published guidance says a recruit with vitiligo “may be found fit.” Indian Air Force officer standards are much stricter about patches on exposed skin. Russia's military-medical schedule measures patches in centimeters. And in Brazil, a study of 97 military, police and firefighting recruitment notices issued between 2009 and 2022 found that 55 excluded people with vitiligo from at least some positions. We compared these rules in our guide to military fitness rules and common questions.
Then there's cause. Military service itself has not been established as a cause of vitiligo, but service life can involve factors associated with its onset or progression, including psychological stress, certain chemical exposures and repeated skin friction, which may trigger new patches through the Koebner phenomenon. Establishing whether any of these contributed to an individual's disease is much harder, especially when veterans' disability benefits depend on demonstrating a connection. Our FAQ on vitiligo and military service explains the distinction.
What remains poorly understood is the journey through care itself: what happens during training, deployments and transfers, and how treatment continues after leaving service. That gap is why we came to Miramar.
Miramar welcomes Honor Without Exception
On Saturday, November 14, Massé World hosted Honor Without Exception at Miramar City Hall, bringing together veterans, service members, clinicians, researchers, policymakers and patient advocates.
Special Recognition
Special thanks go to Mayor Wayne Messam and the City of Miramar for opening City Hall to this conversation. Holding a patient-focused health symposium in a civic building sends a clear message: access to care, dignity and equal opportunity aren't just medical concerns. They're community concerns too.
Massé World, a Florida nonprofit supporting people with vitiligo and albinism, developed the program around the intersection of military service, healthcare access and lived experience. The organizing team, led by Raissa Levy, Founder and President; Nichole Whitehurst, Chief Operating Officer; and Sandi Ring, Director of Community and Patient Engagement, spent six months bringing the event together.
Alisha Archibald, best known for her “So Rare They Stare” awareness campaign, opened with the keynote address, setting the tone for a day devoted to personal experience, dignity and the right to be seen without being defined by a skin condition.
The speaker lineup reflected the breadth of the subject. Florida State Senator Rosalind Osgood and State Representative Felicia Robinson brought the policy perspective. They were joined by scientist and health policy executive Dr. Irene O. Aninye, Dr. James Lee and Matthew Lozosky of Incyte, and mental health counselor and Army veteran Stefanie Sherman.
Dermatologist Dr. Steven Daveluy joined virtually after his flights were cancelled, while Dr. Richard Huggins made a welcome, previously unannounced appearance through a recorded video presentation.
Military and veteran voices included Hannah Metheny, a U.S. Army clinical research coordinator; Army veteran Laurence De Weever; Air Force veterans Briya Fitzgerald and Greg Parmer; and Marine Corps veteran Stephen Taylor.
Tonja Johnson chaired the panel on Treatment Access and Pharmaceutical Innovation, examining the practical barriers to care and what research and industry can do to improve treatment options.
Throughout the day, discussions moved from lived experience and clinical science to treatment access, the Patient Journey Map, policy and healthcare equity. The different perspectives helped connect what medicine can offer with what patients can realistically obtain while meeting the demands of service.
Two new research projects get underway
For the Vitiligo Research Foundation, Honor Without Exception provided the launchpad for two complementary patient surveys. Both aim to replace assumptions with evidence, but each approaches the problem from a different direction.
Research Study 01 / Patient Decisions
Would You Join a Clinical Trial?
Why do people agree, or decline, to participate in dermatology research? Instead of simply asking whether someone is interested in clinical trials, we present practical trade-offs involving expected benefits, placebo probabilities, treatment burden, risks, travel and decisions involving children.
The project grew out of discussions at World Vitiligo Day 2026 in India and is expanding internationally. We want clinical studies to reflect how patients actually make decisions, rather than how researchers assume they do.
Research Study 02 / Military and First Responders
Vitiligo in Uniform: Help Us Map the Road to Care
This study focuses on people with vitiligo who serve or have served in the military, as well as firefighters, emergency medical personnel, police and corrections officers.
We want to learn where people first sought care, how occupational requirements affected their treatment, and what happened when they moved between assignments, deployments or healthcare systems. Their experiences will help us test and refine the proposed Duty Line on the Vitiligo Patient Journey Map.
Both surveys are voluntary and anonymous. Participants may receive a complimentary electronic copy of the updated third edition of A No-Nonsense Guide to Vitiligo during the respective promotional periods. The clinical trial survey's e-book offer runs through December 30, 2026, subject to availability.
From Military Line to Duty Line: when the map meets reality
Toward the end of the symposium, I presented the updated Vitiligo Patient Journey Map, including a proposed Military Line.
For those unfamiliar with the project, the Map represents the patient experience as a subway network, complete with routes, stations, detours and destinations. Everyone begins at White Spot, but the journey afterward depends on access to treatment, professional advice, family support, personal choices and, occasionally, plain luck.
The Highlands represent the medical route through doctors, clinics, insurance and treatments. Foggy Bottom is where misleading advice, miracle cures and frustrating detours can consume months or years. Long Island covers the human side of vitiligo: relationships, emotional support and self-acceptance. The Map has two equally valid destinations: Spotless, representing successful treatment, and Beautiful, representing acceptance and living comfortably with vitiligo.
The original Map was designed around civilian healthcare. Our proposed Military Line attempted to capture the different route followed by people in uniform, but we deliberately presented it only at the end of the symposium, after participants had begun completing the surveys. Showing people our assumptions first might have influenced their answers. We wanted to learn where the stations actually belonged, not collect polite confirmation of a route we'd already drawn.
And the approach paid off. Conversations with service members and veterans, together with dozens of completed paper questionnaires collected during the event, quickly revealed ways to improve the design. By the end of the day, we had revised the proposed Military Line into a more logical Duty Line.
Patient Journey Map • Revised Working Concept
The New Duty Line
The main route follows military service. Deployment is a loop from Base, not a compulsory stop.
DEPLOYMENT CIRCLE
Base → Deployed → Base
May repeat with successive deployments
Conceptual illustration, not the final technical map. The VA connection represents one U.S. veteran-care pathway; other countries and healthcare arrangements differ.
The revised route follows the sequence of military service: Enlistment → Boot Camp → Base → Separation → VA. Base is a two-dot interchange and the central station for active-duty service. From Base, a separate Deployment Circle runs to Deployed and returns to Base, allowing for repeated deployments without making deployment itself a compulsory stage of everyone's journey. The Duty Line eventually leaves that loop at Base and continues through Separation toward the VA, representing a U.S. veteran healthcare pathway.
It's a small change on paper, but an important improvement in logic. The new design distinguishes the basic progression of military service from the repeated cycles of deployment, while giving us a clearer structure for examining interruptions to treatment and continuity of care.
This remains a working model, not a final research finding. Other countries have different military and veteran healthcare systems, and first responders may need their own branch. But the experience in Miramar demonstrated exactly why the Map is being developed with patients rather than simply presented to them.
If our proposed route turns out to be wrong, excellent. Better to learn that now than publish a beautiful map of a road nobody travels.
A question of visibility
Miramar also left me thinking about something that wasn't on the agenda: the changing public face of vitiligo.
Looking around the room, and reflecting on many similar gatherings, I was struck by how strongly people with darker skin are represented in vitiligo advocacy. I see a similar pattern in awareness campaigns, social media and stock photographs, where extensive depigmentation against darker skin has become almost the defining image of the condition. There's an understandable reason for this: the contrast is more visible, and often the social consequences are, too. But vitiligo affects every skin tone, including people whose patches a casual observer would barely notice.
The contradiction becomes apparent when we compare that public visibility with clinical research. In the pivotal ruxolitinib cream trials, for example, approximately 82% of participants were White and only 5% were Black. Other vitiligo treatment studies have reported similar imbalances.
An Emerging Question for Vitiligo Advocacy
We may be creating a curious contradiction in vitiligo: the people most visible in awareness campaigns are among the least represented in clinical trials. Meanwhile, patients whose vitiligo is less visually obvious may struggle to see themselves in public advocacy.
Visibility is not representation, and representation is not access.
Of course, one conference audience cannot establish a broader trend, and racial identity, natural skin tone and the extent of depigmentation are not interchangeable measures. But the contrast deserves closer examination. I'll return to this question in a separate article about how vitiligo is portrayed publicly, who participates in clinical research, and whether our efforts to make the condition more visible have inadvertently left some patients out of the picture.
For now, Honor Without Exception offered a useful reminder that advocacy must reach beyond the faces we see most often. The goal isn't simply to make vitiligo visible. It's to make sure everyone living with it has a voice.
From conversations to evidence
The nationwide aviation disruptions prevented some registered participants from reaching Miramar, considerably reducing attendance. Even so, the discussions were productive and the response to our research exceeded expectations. By the time the symposium wrapped up, dozens of questionnaires had been collected, responses were arriving online, and the first practical revision of the Duty Line was already taking shape.
Special thanks to Massé World, particularly Raissa Levy, Nichole Whitehurst and Sandi Ring, whose six months of preparation made this gathering possible. Thanks also to Mayor Wayne Messam and the City of Miramar for hosting, and to the speakers, volunteers and community partners who contributed their time and expertise. We appreciate the support of sponsor Incyte and the participating organizations, including the Coalition of Skin Diseases, the National Alliance on Mental Illness, Zanderm and the University of Miami Miller School of Medicine.
The next step is to turn these early observations into reliable evidence. The Vitiligo in Uniform survey continues through December 30, 2026, with plans to expand internationally, while the clinical trial study will examine patient decisions across countries and healthcare systems.
If you have relevant experience, we'd love to hear from you.
Survey 01 • Until December 30
Vitiligo in Uniform
For military personnel, veterans and first responders living with vitiligo. Help us map the real road to care.
About 5 minutes • Anonymous
English survey EspañolSurvey 02 • E-book offer through December 31
Would You Join a Clinical Trial?
Help researchers understand what really influences decisions to join dermatology trials, including decisions for children.
5–7 minutes • Anonymous
English survey EspañolBoth surveys are voluntary and anonymous. A complimentary updated third-edition vitiligo ebook is offered under the conditions described on each survey page, while supplies and promotional periods last.
Honor Without Exception was a useful reminder that good research doesn't always begin with better answers. Sometimes it begins when someone looks at your carefully prepared map and tells you that you've put the station in the wrong place.
As for the flight home to Toronto, I'm making no predictions. The aviation gods have already had quite enough fun at my expense this week.
Yan Valle
CEO & Executive Director
Vitiligo Research Foundation
Continue Exploring
Suggested Reading
More context on military service, healthcare access and how you can help improve the Patient Journey Map.
Featured • Research Survey
Vitiligo in Uniform: Help Us Map the Road to Care →
What happens to vitiligo care during service, deployment and the transition to civilian life? Learn how VRF is mapping those gaps and how your experience can contribute to the research.
Practical Guide
Vitiligo in the Military: Fitness Rules and Common Questions →
Can you enlist with vitiligo? Can you remain in service? A comparison of military medical standards and the paperwork behind the answers.
Frequently Asked Question
Is There a Link Between Vitiligo and Military Service? →
Stress, repeated friction and chemical exposures may play a role, but establishing a service connection is a different question. Here's what we know and what remains uncertain.
Listen & Learn
🎙️ Deep Dive in Vitiligo
Three companion episodes explore veterans' benefits, the practical realities of vitiligo in uniform, and the larger challenges of finding lasting treatments.
EPISODE 83
Vitiligo, Veterans, and the 10% Rule →
How the VA evaluates vitiligo, what the 10% disability rating means, and the practical steps and supporting paperwork veterans may need when preparing a claim.
EPISODE 77
Vitiligo in Uniform: Same Disease, Different System →
From medical fitness and deployment to treatment access, service records and veteran care, this episode follows the challenges that arise when vitiligo meets military life.
EPISODE 80
Why There Is Still No Cure for Vitiligo →
Why haven't decades of research delivered a permanent cure? A look at biology, clinical development, pharmaceutical economics and the realities behind difficult treatment decisions.
Prefer listening on your usual podcast app? Explore all episodes of Deep Dive in Vitiligo →